MINI FUTURE SHORT - MERCK & CO. Stock

Certificat

DE000PN7NV72

Market Closed - Deutsche Boerse AG 15:50:30 2024-05-10 EDT
2.68 EUR -0.37% Intraday chart for MINI FUTURE SHORT - MERCK & CO.
Current month-4.63%
1 month-11.26%
Date Price Change Volume
24-05-10 2.68 -0.37% 0
24-05-09 2.69 -1.82% 0
24-05-08 2.74 +1.48% 0
24-05-07 2.7 -8.47% 0
24-05-06 2.95 +0.34% 0

Delayed Quote Deutsche Boerse AG

Last update May 10, 2024 at 03:50 pm

More quotes

Static data

Product typeKnock-Out mit Stop Loss
Buy / SellPUT
Underlying MERCK & CO., INC.
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PN7NV7
ISINDE000PN7NV72
Date issued 2023-08-22
Strike 159.3 $
Maturity Unlimited
Parity 10 : 1
Emission price 4.66
Emission volume N/A
Settlement Barausgleich
Currency EUR

Technical Indicators

Highest since issue 5.73
Lowest since issue 2.42
Spread 0.01
Spread %0.37%

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
130.1 USD
Average target price
141.6 USD
Spread / Average Target
+8.90%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW